Gossamer Bio, Inc. financial data

Symbol
GOSS on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 491% % -29%
Debt-to-equity -1094% % -330%
Return On Equity 594% %
Return On Assets -60% % -170%
Operating Margin -365% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 231,456,247 shares 2.1%
Common Stock, Shares, Outstanding 231,306,125 shares 2.1%
Entity Public Float $197,400,000 USD 101%
Common Stock, Value, Issued $24,000 USD 4.3%
Weighted Average Number of Shares Outstanding, Basic 227,981,475 shares 0.72%
Weighted Average Number of Shares Outstanding, Diluted 227,981,475 shares 0.72%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $44,051,000 USD 40%
General and Administrative Expense $36,122,000 USD 0.91%
Operating Income (Loss) $160,817,000 USD -121%
Nonoperating Income (Expense) $2,246,000 USD -50%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $48,221,000 USD -51%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $156,161,000 USD -118%
Earnings Per Share, Basic 0 USD/shares -518%
Earnings Per Share, Diluted 0 USD/shares -518%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,933,000 USD -69%
Marketable Securities, Current $171,291,000 USD -43%
Accounts Receivable, after Allowance for Credit Loss, Current $9,243,000 USD 40%
Assets, Current $203,989,000 USD -41%
Property, Plant and Equipment, Net $70,000 USD -77%
Operating Lease, Right-of-Use Asset $4,354,000 USD -28%
Other Assets, Noncurrent $407,000 USD 44%
Assets $208,820,000 USD -40%
Accounts Payable, Current $1,116,000 USD -63%
Employee-related Liabilities, Current $11,970,000 USD 20%
Accrued Liabilities, Current $19,291,000 USD 11%
Contract with Customer, Liability, Current $23,974,000 USD 18%
Liabilities, Current $62,117,000 USD 22%
Contract with Customer, Liability, Noncurrent $27,079,000 USD -38%
Operating Lease, Liability, Noncurrent $3,700,000 USD -19%
Liabilities $291,153,000 USD -1.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $5,107,000 USD -129%
Retained Earnings (Accumulated Deficit) $1,391,700,000 USD -13%
Stockholders' Equity Attributable to Parent $82,333,000 USD -252%
Liabilities and Equity $208,820,000 USD -40%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $39,724,000 USD 24%
Net Cash Provided by (Used in) Financing Activities $504,000 USD
Net Cash Provided by (Used in) Investing Activities $22,062,000 USD -64%
Common Stock, Shares Authorized 700,000,000 shares 0%
Common Stock, Shares, Issued 231,306,125 shares 2.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,053,000 USD -352%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,933,000 USD -69%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $228,683,000 USD 3.3%
Deferred Tax Assets, Gross $229,769,000 USD 3.4%
Operating Lease, Liability $4,619,000 USD -27%
Payments to Acquire Property, Plant, and Equipment $26,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $159,037,000 USD -117%
Lessee, Operating Lease, Liability, to be Paid $5,867,000 USD -28%
Property, Plant and Equipment, Gross $193,000 USD -97%
Operating Lease, Liability, Current $919,000 USD -47%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,406,000 USD 0.64%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,417,000 USD -6.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,248,000 USD -33%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,448,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $97,940,000 USD -20%
Unrecognized Tax Benefits $13,919,000 USD 1.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,237,000 USD -15%
Operating Lease, Payments $2,700,000 USD -23%
Depreciation, Depletion and Amortization $580,000 USD -59%
Share-based Payment Arrangement, Expense $12,622,000 USD -55%
Interest Expense $13,140,000 USD -5.6%